| [1] |
王诏, 汪雪雁. 先天性膈疝的遗传咨询和严重性评估简述. 中国计划生育和妇产科, 2022, 14(12): 61-64.
|
| [2] |
Harper PS. Practical Genetic Counselling. Translated by Zhi Xia. Beijing: Science Press, 2017.
|
|
P.S.哈珀. 实用遗传咨询. 夏志, 译. 北京: 科学出版社, 2017.
|
| [3] |
Liu W, Yang L, Guo F, Zuo J. Curriculum design and teaching implementation of Blended Teaching Course “Rare Genetic Diseases”. Chin J Birth Health Hered, 2024, 32(8): 1752-1755.
|
|
刘雯, 杨玲, 郭锋, 左伋. “罕见遗传病”混合式课程的设计与教学实施. 中国优生与遗传杂志, 2024, 32(8): 1752-1755.
|
| [4] |
Uhlenbusch N, Löwe B, Depping MK. Perceived burden in dealing with different rare diseases: a qualitative focus group study. BMJ Open, 2019, 9(12): e033353.
pmid: 31888936
|
| [5] |
World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: WHO, 2001.
|
| [6] |
Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. Lancet, 2022, 399(10343): 2310-2324.
pmid: 35691301
|
| [7] |
Chen MY. A case intervention study on alleviating caregiving stress among First-Degree relatives of individuals with mental disorders[Dissertation]. Sichuan International Studies University, 2025.
|
|
陈明燕. 缓解精神障碍患者一级亲属照护压力的个案介入研究[学位论文]. 四川外国语大学, 2025.
|
| [8] |
冯淑娴, 岳小珍. 产前四维彩超诊断胎儿软骨发育不全合并鼻骨缺失1例. 中国优生与遗传杂志, 2021, 29(5): 694-695.
|
| [9] |
俞晓敏. 遗传性肾脏疾病基因诊断策略. 肾脏病与透析肾移植杂志, 2023, 32(3): 247-248.
|
| [10] |
潘锋. 多学科综合管理有助于延缓杜氏肌营养不良疾病进展. 妇儿健康导刊, 2025, 4(20): 4-8.
|
| [11] |
Zhang YX, Xie HT, Liang GX, Qin YR, Wei XF, Ning SS, Liang Y, Liang XD, Xie YL, Lin ZZ, Zhu DN, Lin JQ, Xiong F, Xu XM, Shang X. A novel gain-of-function PIP4K2A mutation elevates the expression of β-globin and aggravates the severity of α-thalassemia. Br J Haematol, 2023, 202(5): 1018-1023.
pmid: 37423903
|
| [12] |
Ratna H. Heritable retinoblastoma and risk of developing second primary cancer. JAMA Netw Open, 2020, 3(10): e2022569.
pmid: 33090221
|
| [13] |
Pohjola P, de Leeuw N, Penttinen M, Kääriäinen H. Terminal 3p deletions in two families—correlation between molecular karyotype and phenotype. Am J Med Genet A, 2010, 152A(2): 441-446.
pmid: 20101686
|
| [14] |
Zhou TT, Pan J. Study on affordability of orphan drugs under different health insurance levels: a case study of spinal muscular at-rophy. Chin Health Econ, 2022, 41(2): 33-38.
|
|
周婷婷, 潘杰. 不同保障水平下罕见病用药可负担性研究:以脊髓性肌萎缩症为例. 中国卫生经济, 2022, 41(2): 33-38.
|
| [15] |
Li MJ, Li Q, Zhao MM, Kim H, Feng RQ, Guo MN, Heng JP, Yang JK, Liu C. Spectrum and epidemiology of rare diseases in a Chinese natural population of 14.31 million residents, 2012-2023. Orphanet J Rare Dis, 2025, 20(1): 410.
pmid: 40775651
|
| [16] |
Takahashi S, Iizuka R, Sawai T. Reevaluating ‘seriousness’ in genetic conditions: balancing clinical criteria and lived experiences. Eur J Hum Genet, 2025, 33(6): 699-700.
pmid: 40089638
|
| [17] |
Berry GT. Classic Galactosemia and Clinical Variant Galactosemia[M/OL]. GeneReviews®. Seattle: University of Washington, 1993-2025[2021.03.11].
|